Stock VELO VELOXIS PHARMACEUTICALS A/S
Add to a list
To use this feature you must be a member
Log inSign up

News Veloxis Pharmaceuticals A/S

Equities

VELO

DK0060048148

Delayed Nasdaq Copenhagen
Other stock markets
 		5-day change 1st Jan Change
- DKK -.--% Intraday chart for Veloxis Pharmaceuticals A/S -.--% -0.50%
2022 Veloxis Pharmaceuticals Announces Dosing of the First Patient by partner Xenikos in the Global Phase 3 Study Evaluating T-Guard(R) in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD) CI
2021 Veloxis Pharmaceuticals, Inc entered into a global license agreement to acquire Worldwide Rights to FR104 from OSE Immunotherapeutics SA. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Veloxis Pharmaceuticals Announces Dosing of the First Patient by partner Xenikos in the Global Phase 3 Study Evaluating T-Guard(R) in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)
CI
Scandion Oncology A/S : appoints Johnny Stilou as new CFO
AQ
Veloxis Pharmaceuticals, Inc entered into a global license agreement to acquire Worldwide Rights to FR104 from OSE Immunotherapeutics SA.
CI
Veloxis Pharmaceuticals A/S : Extraordinary General Meeting of Veloxis Pharmaceuticals A/S, 17 February 2020
AQ
Veloxis Pharmaceuticals A/S Announces Board Appointments
CI
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from OMX Nordic All-Share Index
CI
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from S&P Global BMI Index
CI
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from S&P Global BMI Index
CI
Veloxis Pharmaceuticals A/S : Nasdaq Copenhagen A/S has Accepted Veloxis Pharmaceuticals A/S' Request for Delisting of its Shares from Nasdaq Copenhagen A/S
AQ
Veloxis Pharmaceuticals A/S : - Notice to Convene Extraordinary General Meeting
AQ
Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S
AQ
Veloxis Pharmaceuticals A/S : - Major Shareholder Notifications
AQ
Veloxis Pharmaceuticals A/S : Notice to Convene Extraordinary General Meeting
AQ
Veloxis Pharmaceuticals A/S : Announcement of Request for Delisting of Veloxis Pharmaceuticals A/S' Shares from Nasdaq Copenhagen
AQ
Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S
AQ
Veloxis Pharmaceuticals A/S: Major Shareholder Notifications
AQ
Veloxis Pharmaceuticals A/S : Increases Share Capital in Connection with Asahi Kasei Pharma Denmark's Exercise of Warrants Acquired under the Public Tender Offer
AQ
Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer
AQ
Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer
AQ
Veloxis Pharmaceuticals A/S : - Reporting of Managers and Closely Associated Persons Transactions in Veloxis-Shares and Financial Instruments Linked Hereto
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VELO Stock
  4. News Veloxis Pharmaceuticals A/S